Breaking News Instant updates and real-time market news.

MU

Micron

$48.39

0.83 (1.75%)

, WDC

Western Digital

$53.84

2.21 (4.28%)

06:12
11/04/19
11/04
06:12
11/04/19
06:12

Ross to Bloomberg: Licenses for U.S companies to sell to Huawei coming 'shortly'

U.S. Commerce Secretary Wilbur Ross says licenses for U.S. companies to sell components to China's Huawei will come "very shortly," Bloomberg's Philip Heijmans and Haslinda Amin report. Ross told Bloomberg that the licenses "will be forthcoming very shortly" and that the U.S. government had received 206 requests. "That's a lot of applications -- it's frankly more than we would've thought," Ross added. Huawei suppliers include Micron Technology (MU) and Western Digital (WDC), while makers of optical components, including Oclaro (OCLR), Acacia Communications (ACIA), NeoPhotonics (NPTN), Lumentum (LITE), and Finisar (IIVI), have previously reacted negatively to headlines regarding U.S. enforcement actions and allegations against China's Huawei. Reference Link

MU

Micron

$48.39

0.83 (1.75%)

WDC

Western Digital

$53.84

2.21 (4.28%)

OCLR

Bought by LITE

$0.00

(0.00%)

ACIA

Acacia Communications

$66.24

0.61 (0.93%)

NPTN

NeoPhotonics

$7.95

1.38 (21.00%)

LITE

Lumentum

$65.18

2.51 (4.01%)

IIVI

II-VI

$34.22

1.06 (3.20%)

  • 06

    Nov

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

MU Micron
$48.39

0.83 (1.75%)

10/23/19
BARD
10/23/19
NO CHANGE
Target $30
BARD
Underperform
Micron files annual report, macro trends remain overwhelming, says Baird
Baird analyst Tristan Gerra notes that Micron filed its 2019 annual report in a 10-K last week, with free cash flow in Q4 at $184M, down from $2.9B in Q4 2018. Additionally, total inventories increased 4% sequentially, revenue from Huawei was 12% of total revenue in 2019, and Micron repurchased a total of 67M shares for $2.66B in 2019, he adds. While the analyst believes Micron's fundamentals have significantly improved versus prior cycles, macro trends remain overwhelming. Gerra thinks it is too early to buy the stock as recovery expectations will likely get further delayed. He has an Underperform rating and $30 price target on the shares.
10/22/19
BERN
10/22/19
NO CHANGE
BERN
Outperform
Bernstein sees signs of bottoming/recovery starting in 2020 for DRAM, NAND
Bernstein analyst Mark Newman says that though Memory industry profits remain challenged following downturns in both DRAM and NAND, he sees signs of bottoming and recovery starting in 2020 for both DRAM and NAND. His Top picks are SK Hynix and Micron (MU) followed by Samsung (SSNLF), all rated Outperform.
10/01/19
KEYB
10/01/19
NO CHANGE
KEYB
KeyBanc makes four Semiconductor rating changes after trip to Asia
KeyBanc analyst Weston Twigg made four rating changes in the Semiconductors space after his quarterly trip to Asia revealed overall demand trends, while still weak, "are not getting worse." The analyst was encouraged to find inventories are beginning to normalize and that expectations are for normal seasonality in Q4. As a result, he upgraded Analog Devices (ADI), Microchip (MCHP), and NXP Semiconductors (NXPI) to Overweight from Sector Weight. Conversely, the China insourcing trends at Huawei and other manufacturers are accelerating faster than Twigg had expected, which results in his downgrade of Xilinx (XLNX) to Sector Weight from Overweight. The analyst also recommends building long-term positions in semi-cap and memory stocks like KLA-Tencor (KLAC), Teradyne (TER), Micron Technology (MU), MKS Instruments (MKSI), Entegris (ENTG), Applied Materials (AMAT) and Lam Research (LRCX). Lastly, Twigg says that initial demand for Apple's (AAPL) new iPhone "appears to be slightly worse than expected."
10/11/19
CLVD
10/11/19
NO CHANGE
CLVD
Neutral
Cleveland Research raises Micron estimates for November quarter, sees risk after
Cleveland Research analyst Chandler Converse raised his estimates for Micron's November-end quarter to account for improved NAND pricing and buy-ahead that he sees driving upside in volume. However, he sees risks to the February-end quarter given his concerns about inventory build at customers, CPU supply challenges and seasonality. Converse has a Neutral rating on Micron shares.
WDC Western Digital
$53.84

2.21 (4.28%)

10/14/19
LOOP
10/14/19
UPGRADE
LOOP
Buy
Western Digital upgraded to Buy from Hold at Loop Capital
10/14/19
LOOP
10/14/19
UPGRADE
Target $75
LOOP
Buy
Western Digital upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Ananda Baruah upgraded Western Digital to Buy from Hold with a price target of $75, up from $50. The analyst cites his findings that flash memory average selling prices are set to increase starting in the September and December quarters while also sustaining those increases in 2020, along with expectations of strong hyperscale HDD demand next year. Baruah is modeling his price target with an assumed 2021 earnings multiple of 10-times, but adds that there is potential for that multiple to rise to 12- to 15- times if Western Digital can grow its revenue by about 15% in 2020.
10/31/19
RBCM
10/31/19
NO CHANGE
Target $64
RBCM
Outperform
Western Digital price target lowered to $64 from $70 at RBC Capital
RBC Capital analyst Mitch Steves lowered his price target on Western Digital to $64, saying that while its Q1 earnings were "solid", the Q2 guidance was weaker because of "limited margin flow through." The analyst still keeps his Outperform rating on the stock, citing the management's view that the bottom in NAND memory cycle is now in the past as the company works toward gross margins of over 40%.
10/14/19
10/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Neutral from Underperform at BofA/Merrill with analyst Robert Ohmes saying that he expects the "accelerated democratization" of the brand to offset the broader future challenges around "significant" third-party retail store closures and global stagnation in "performance" footwear/apparel. 2. Western Digital (WDC) upgraded to Buy from Hold at Loop Capital with analyst Ananda Baruah citing his findings that flash memory average selling prices are set to increase starting in the September and December quarters while also sustaining those increases in 2020, along with expectations of strong hyperscale HDD demand next year. 3. Varian Medical (VAR) upgraded to Buy from Neutral at BTIG with analyst Sean Lavin saying Varian shares have pulled back in recent weeks and now trade in line with the comp group. 4. Xilinx (XLNX) upgraded to Buy from Neutral at Nomura Instinet with analyst David Wong saying many risks remain for U.S. semiconductor companies, including uncertainties related to U.S./China trade issues and U.S. action against Chinese companies such as Huawei. 5. HP Enterprise (HPE) upgraded to In Line from Underperform at Evercore ISI with analyst Amit Daryanani saying he is incrementally more positive on cash flow resiliency, the Cray acquisition, recent data points that indicate H3C is performing better than other OEMs in China, and valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
OCLR Bought by LITE
$0.00

(0.00%)

11/12/18
CHLM
11/12/18
DOWNGRADE
Target $24
CHLM
Hold
Finisar downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon downgraded Finisar (FNSR) to Hold from Buy and raised his price target on the shares to $24 from $23. The analyst believes that II-VI's (IIVI) $26/share cash and stock offer for the company, which was a 38% premium to the close on November 8th, is more than a fair deal, given that Lumentum's (LITE) offer premium for Oclaro (OCLR) earlier this year was 27%. Shannon has some doubts about whether this deal will close given the Lumentum/Oclaro deal has not yet closed and the intensifying political standoff between the US and China, but also admits II-VI and Finisar would not have agreed to this deal if there was not a good chance of closing.
11/13/18
PIPR
11/13/18
NO CHANGE
Target $72
PIPR
Overweight
Piper remains buyer of Lumentum following yesterday's 33% decline
Piper Jaffray analyst Troy Jensen remains a buyer of Lumentum (LITE) shares following yesterday's 33% decline. The reduced forecast at Apple (AAPL) has nothing to do with lost share for Lumentum, rather it is more indicative of lower sales forecasts at this key account, Jensen tells investors in a research note. The analyst continues to believe the 3D sensing market "will grow handsomely" with Apple and he notes that Android phones are just beginning their adoption. He also sees a pending opportunity for world facing 3D sensing applications. Further, the core telco optics market is in the early innings of an upgrade cycle, which should provide a "nice tailwind" for Lumentum, says Jensen. He also thinks the pending acquisition of Oclaro (OCLR) could also be a catalyst for the shares given the earnings accretion once the merger gets approval. The analyst lowered his price target for Lumentum to $72 from $85 and reiterates an Overweight rating on the name.
12/06/18
MKMP
12/06/18
DOWNGRADE
MKMP
Neutral
Finisar downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Michael Genovese downgraded Finisar (FNSR) to Neutral from Buy with a price target of $24 after its merger agreement with II-VI (IIVI) announced last month. The analyst further notes that Q4 is trending well for the optical components group which also includes Lumentum (LITE) and Oclaro (OCLR), but believes that the guidance for March will be "sequentially down due to annual price negotiations and Chinese New Year".
12/17/18
NEED
12/17/18
NO CHANGE
Target $75
NEED
Strong Buy
Lumentum can continue posting 'beat and raise' quarters, says Needham
Needham analyst Alex Henderson left recent meetings with management with a "strong conviction" that Lumentum can continue to post "beat and raise" quarters. With the Oclaro deal closed, the analyst increased his estimates for Lumentum to reflect the combined company numbers. He believes the company looks well positioned and keeps a Strong Buy rating on the shares with a $75 price target.
ACIA Acacia Communications
$66.24

0.61 (0.93%)

09/23/19
NORL
09/23/19
NO CHANGE
NORL
Underperform
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans
Northland analyst Tim Savageaux says datapoints at the European Conference on Optical Communication support his caution on the timing of 400G ramps both inside/outside the data center, driven in part by technical complexity. Datapoints at the show indicate a "large cut" in 400G rollout plans at Amazon.com (AMZN) this year, which poses a "significant risk" to Inphi (IPHI), the analyst tells investors in a research note. Shares of Inphi are well off their lows on the day but remain down 5% to $60.48 in early afternoon trading. Savageaux also believes that consensus views overestimate the possible impact of the Cisco Systems (CSCO)/Acacia Communications (ACIA) merger on Inphi's coherent application-specific integrated circuit unit. He believes Lumentum (LITE) is more likely to benefit with its Acacia -powered CFP2 DCO platform in the near term. Further, the analyst's early update from the European Conference on Optical Communication is positive for NeoPhotonics (NPTN). Positive Huawei demand dynamics is a notable plus for the company, says Savageaux. He has an Underpeform rating on Inphi, and Outperform ratings on both Lumentum and NeoPhotonics.
07/18/19
JPMS
07/18/19
NO CHANGE
Target $53
JPMS
Overweight
JPMorgan boosts Ciena target to $53, sees further share upside
JPMorgan analyst Samik Chatterjee raised his price target for Ciena (CIEN) to $53 from $50 saying he sees further upside in the shares. The analyst sees ~$2B of incremental revenue opportunity for the company through continued consolidation of share away from sub-scale optical system companies, a ~$2.4B opportunity through accelerated share wins from entrenched players, and "strong" growth opportunities in its Metro segment, which he believes is levered to benefit the most from 5G investments. Further, investor sentiment on Ciena shares stands to "improve materially" as competitive concerns relating to Acacia Communications' (ACIA) product look overdone, Chatterjee tells investors in a research note. He keeps an Overweight rating on the name.
07/16/19
RSBL
07/16/19
DOWNGRADE
RSBL
Neutral
Acacia Communications downgraded to Neutral from Buy at Rosenblatt
Rosenblatt analyst Ryan Koontz downgraded Acacia Communications (ACIA) to Neutral from Buy citing the acquisition agreement by Cisco (CSCO).
07/11/19
MKMP
07/11/19
NO CHANGE
Target $54
MKMP
Buy
Ciena investment case is strengthening, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $54 price target on Ciena (CIEN), saying the "very good investment case" on the stock is "strengthening" after his discussions with the company's SVP of Global Products. The analyst notes that the company has been gaining 1%-1.5% of market share in China annually for the past 5 years and believes that it can gain another 1%-3% this year since the competitive intensity from Acacia (ACIA) and Nokia (NOK) "did not materialze".
NPTN NeoPhotonics
$7.95

1.38 (21.00%)

09/18/19
RILY
09/18/19
DOWNGRADE
Target $6.5
RILY
Neutral
NeoPhotonics downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst David Kang downgraded NeoPhotonics to Neutral from Buy with a price target of $6.50. The analyst cites valuation and uncertainties from the Huawei ban for the downgrade.
08/06/19
08/06/19
UPGRADE
Target $7

Buy
NeoPhotonics upgraded to Buy at MKM Partners on reduced Huawei ban impact
As previously reported, MKM Partners analyst Michael Genovese upgraded NeoPhotonics to Buy from Neutral and raised his price target to $7 from $5 after its Q2 earnings beat and above consensus outlook for Q3. The analyst notes that the company has determined that most of the products it ships to Huawei are not subject to the Entity List restrictions, with good demand being seen for its 100G/200G products. Genovese further cites the 28% sequential increase in sales to the company's next four largest customers after Huawei, stating that demand trends are strong across Telecom and DCI applications.
08/06/19
MKMP
08/06/19
UPGRADE
MKMP
Buy
NeoPhotonics upgraded to Buy from Neutral at MKM Partners
LITE Lumentum
$65.18

2.51 (4.01%)

10/31/19
CHLM
10/31/19
NO CHANGE
Target $85
CHLM
Buy
Lumentum price target raised to $85 from $75 at Craig-Hallum
Craig-Hallum analyst Rich Shannon said Lumentum's (LITE) "good" report and strong guidance show that it is not just an Apple (AAPL) 3D sensing play but also has strength in Telecom and Datacom. Lumentum's current valuation suggests investors are awarding a low multiple to the Apple business, but he believes diversification within and outside of 3D sensing will "provide reasons for investors to give it a valuation it deserves." He keeps a Buy rating on Lumentum shares and raised his price target on the stock to $85 from $75.
10/31/19
PIPR
10/31/19
NO CHANGE
Target $72
PIPR
Overweight
Piper says record gross margin 'biggest surprise' from Lumentum report
Piper Jaffray analyst Troy Jensen said Lumentum beat expectations "across the board" in Q1, powered by outperformance in 3D sensing, calling the company's record gross margin of 45.8% the "biggest surprise" about the quarter. A strong outlook for 3D sensing, sustained strength in telco optics and a "hopeful rebound" in industrial lasers leads Jensen to keep an Overweight rating and $72 price target on Lumentum shares.
10/03/19
DADA
10/03/19
NO CHANGE
Target $75
DADA
DA Davidson lowers FY20 EPS view on Lumentum after transceiver business sale
In a research note issued on October 1st, DA Davidson analyst Thomas Diffely is keeping his Buy rating and $75 price target on Lumetum but lowers his FY20 EPS view by 40c to $4.00 to reflect the company's transceiver business divestment and the "early cadence" of the new iPhone launch toward Q1. The analyst also expects Lumentum's commercial laser business to remain depressed until 2020 amid geo-political uncertainty and an overall soft industrial market, but he still sees the company's photonics chip sales as "doing well" - even though it is off a much lower revenue level. **This story replaces a prior entry which incorrectly stated that Diffely lowered his FY19 EPS outlook.
11/01/19
RILY
11/01/19
NO CHANGE
Target $75
RILY
Buy
Lumentum price target raised to $75 from $71 at B. Riley FBR
B. Riley FBR analyst Dave Kang raised his price target for Lumentum to $75 from $71 and reiterates a Buy rating on the shares following the company's better than expected fiscal Q1 results. Lumentum's growth prospects "remain compelling" in fiscal 2021, as its lead customer introduces 5G models with world facing sensors, resulting in higher dollar content, Kang tells investors in a research note.
IIVI II-VI
$34.22

1.06 (3.20%)

08/14/19
NEED
08/14/19
NO CHANGE
Target $46
NEED
Buy
II-VI price target raised to $46 from $44 at Needham
Needham analyst James Ricchiuti raised his price target on II-VI to $46 and kept his Buy rating after its above-consensus revenue reported in Q4, driven by the "accelerated shipments in the optical communications market." The analyst believes that business in optical communications as well as in A&D will remain "strong", with the company's SiC substrates and 3D sensing growth platforms also positioned for good performance in FY20.
09/23/19
RILY
09/23/19
NO CHANGE
Target $39
RILY
Neutral
II-VI, Finisar merger condition positive for Lumentum, says B. Riley FBR
I-VI Incorporated (IIVI) announced last Friday that it obtained antitrust clearance from the State Administration for Market Regulation of the People's Republic of China for the acquisition of Finisar (FNSR), and one condition is that II-VI and Finisar will separately operate the wavelength selective switch) business for three years, B. Riley FBR analyst Dave Kang tells investors in a research note. This is a positive for Lumentum (LITE) since the condition will limit the combined company's ability to join forces to close the gap, says the analyst, who believes Lumentum has a three-year lead in the high-end WSS segment. The analyst maintains a Buy rating on Lumentum and Neutral rating on II-VI.
09/30/19
NORL
09/30/19
DOWNGRADE
Target $39
NORL
Market Perform
II-VI downgraded to Market Perform on acquisition risks at Northland
As previously reported, Northland downgraded II-VI to Market Perform from Outperform and trimmed its price target to $39 from $42. Analyst Tim Savageaux said II-VI's Finisar acquisition has significant cultural/operational risks, along with risks to Finisar's datacom revenues from SiP competitors. The analyst said immediate firings of multiple senior executives, including Co-CEO's, combined with only 10% accretion from current estimates leads to his downgrade.
09/30/19
NORL
09/30/19
DOWNGRADE
NORL
Market Perform
II-VI downgraded to Market Perform from Outperform at Northland

TODAY'S FREE FLY STORIES

LULU

Lululemon

$231.08

1.58 (0.69%)

07:42
12/10/19
12/10
07:42
12/10/19
07:42
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GOLD

Barrick Gold

$16.85

-0.045 (-0.27%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Barrick Gold to sell 90% interest in Massawa project to Teranga for up to $430M »

Barrick Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$62.68

-1.77 (-2.75%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Sage Therapeutics announces planned progression of SAGE-718 »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$237.33

-4.62 (-1.91%)

07:40
12/10/19
12/10
07:40
12/10/19
07:40
Recommendations
RH analyst commentary  »

RH price target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$54.92

-0.32 (-0.58%)

, AXE

Anixter

$88.88

-0.18 (-0.20%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Upgrade
Wesco, Anixter rating change  »

Wesco upgraded to Strong…

WCC

Wesco

$54.92

-0.32 (-0.58%)

AXE

Anixter

$88.88

-0.18 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NFLX

Netflix

$302.48

-4.88 (-1.59%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Conference/Events
Netflix management to meet with UBS »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

SGEN

Seattle Genetics

$114.26

-3.26 (-2.77%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

SYBT

S.Y. Bancorp

$41.02

-0.03 (-0.07%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Conference/Events
S.Y. Bancorp management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DG

Dollar General

$154.81

0.075 (0.05%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Dollar General announces availability of CBD products in select states »

Dollar General announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HROW

Harrow Health

$6.53

0.04 (0.62%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Harrow Health subsidiary announces outsourcing facility ships to California »

ImprimisRx, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENB

Tenable Holdings

$24.81

-0.46 (-1.82%)

07:36
12/10/19
12/10
07:36
12/10/19
07:36
Recommendations
Tenable Holdings analyst commentary  »

Tenable Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TROW

T. Rowe Price

$124.48

0.59 (0.48%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Hot Stocks
T. Rowe Price reports preliminary AUM $1.18T at November 30 »

Client transfers from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTSV

Forty Seven

$30.44

16.04 (111.39%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Recommendations
Forty Seven analyst commentary  »

Forty Seven price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$47.34

0.62 (1.33%)

, TPR

Tapestry

$25.80

0.26 (1.02%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ZS

Zscaler

$47.34

0.62 (1.33%)

TPR

Tapestry

$25.80

0.26 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 16

    Dec

  • 10

    Jan

FRAN

Francesca's

$19.83

1.29 (6.96%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Earnings
Francesca's reports Q3 adj. EPS ($1.12) vs. ($2.08) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

WH

Wyndham Hotels & Resorts

$57.94

-0.1 (-0.17%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Conference/Events
Wyndham Hotels & Resorts management to meet with Wolfe Research »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CNST

Constellation Pharmaceuticals

$36.15

-7.95 (-18.03%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Recommendations
Constellation Pharmaceuticals analyst commentary  »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

AMGN

Amgen

$232.74

-1 (-0.43%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Hot Stocks
Amgen says Phase 3 CANDOR study met primary endpoint »

Amgen announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$17.10

-0.59 (-3.34%)

, BMRN

BioMarin

$78.87

-1.03 (-1.29%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Invitae launches Discover Dysplasias initiative with BioMarin »

Invitae (NVTA) announced…

NVTA

Invitae

$17.10

-0.59 (-3.34%)

BMRN

BioMarin

$78.87

-1.03 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

, GE

General Electric

$10.99

-0.105 (-0.95%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Allegheny Technologies extends long-term purchase agreements with GE Aviation »

Allegheny Technologies…

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

GE

General Electric

$10.99

-0.105 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

PTON

Peloton

$34.78

2.215 (6.80%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Recommendations
Peloton analyst commentary  »

Peloton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVV

Valvoline

$22.21

-0.17 (-0.76%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Conference/Events
Valvoline management to meet with Buckingham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PCG

PG&E

$11.05

1.4 (14.51%)

07:30
12/10/19
12/10
07:30
12/10/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

LEG

Leggett & Platt

$52.17

-0.91 (-1.71%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$93.83

-1.6 (-1.68%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Recommendations
Addus HomeCare analyst commentary  »

Addus HomeCare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.